StockData
NutriBand Inc. logo

NutriBand Inc. (NTRB) stock

NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)

Close on Nov 17, 2026Market cap $67.95MP/E –Yield –

NutriBand r&d expenses

Research and development expenses are spending on new products and technology.

NutriBand's R&D Expenses for the twelve months ending Jul 31, 2026 was $1.21M, down 53.6% year over year. For fiscal 2026 it was $1.89M, down 39.4% from the year before. The highest annual figure on record is $3.12M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jan 31, 2026$1.89M-39.4%
FY2025Jan 31, 2025$3.12M+59.1%
FY2024Jan 31, 2024$1.96M+99.6%
FY2023Jan 31, 2023$982.23K+138.8%
FY2022Jan 31, 2022$411.38K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jul 31, 2026$322.19K-42.7%
Q1 FY2027CQ1 2026Apr 30, 2026$247.26K-63.8%
Q4 FY2026CQ4 2025Jan 31, 2026$188.04K-61.6%
Q3 FY2026CQ3 2025Oct 31, 2025$457.11K-48.1%
Q2 FY2026CQ2 2025Jul 31, 2025$562.55K-27.3%
Q1 FY2026CQ1 2025Apr 30, 2025$683.43K-29.9%
Q4 FY2025CQ4 2024Jan 31, 2025$489.86K-13.0%
Q3 FY2025CQ3 2024Oct 31, 2024$880.77K+59.7%
Q2 FY2025CQ2 2024Jul 31, 2024$773.98K+73.9%
Q1 FY2025CQ1 2024Apr 30, 2024$974.54K+143.4%
Q4 FY2024CQ4 2023Jan 31, 2024$563.37K+90.4%
Q3 FY2024CQ3 2023Oct 31, 2023$551.50K+89.7%
Q2 FY2024CQ2 2023Jul 31, 2023$445.12K+60.2%
Q1 FY2024CQ1 2023Apr 30, 2023$400.43K+239.9%
Q4 FY2023CQ4 2022Jan 31, 2023$295.83K+18.1%
Q3 FY2023CQ3 2022Oct 31, 2022$290.72K–
Q2 FY2023CQ2 2022Jul 31, 2022$277.87K–
Q1 FY2023CQ1 2022Apr 30, 2022$117.81K–
Q4 FY2022CQ4 2021Jan 31, 2022$250.38K–

More NutriBand figures

See a number that looks wrong?